Ramky Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 14 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -107.95%
(FY 2020)
- Net Worth -9.52%
(FY 2020)
- Total Assets -5.66%
(FY 2020)
About Ramky Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Udaya Modugula, Ramakrishna Munnamgi, and Sanikommu Srikanthreddy serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PLC071719
- Company No.
071719
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2010
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ramky Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanikommu Srikanthreddy  | Director | 02-Feb-2018 | Current |
| Udaya Modugula | Director | 16-Dec-2010 | Current |
| Ramakrishna Munnamgi | Director | 28-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Ramky Life Sciences.
Ramky Life Sciences Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 107.95% decrease in profit. The company's net worth dipped by a decrease of 9.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ramky Life Sciences?
In 2019, Ramky Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kvr Baseline Resources Private LimitedActive 13 years 10 monthsRamakrishna Munnamgi is a mutual person
Chhattisgarh Energy Consortium (India) Private LimitedActive 17 years 11 monthsUdaya Modugula is a mutual person
- Pgkm Infra Projects LimitedActive 14 years 11 months
Udaya Modugula and Ramakrishna Munnamgi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ramky Life Sciences?
Unlock and access historical data on people associated with Ramky Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramky Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramky Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
